Global Pet Arthritis Market Research Report 2023

The increasing companion animal population, growing prevalence of arthritis, rising risk factors for the disease, supportive awareness programs initiated by governments, and strategies implemented by key companies are some of the key factors driving the market.

The global Pet Arthritis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Pet Arthritis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Pet Arthritis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Pet Arthritis in Dogs is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Pet Arthritis include Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC., Vetoquinol, NexGen Pharmaceuticals and Norbrook, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pet Arthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Arthritis.

The Pet Arthritis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pet Arthritis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Arthritis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Arthritis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Osteoarthritis

1.2.3 Other Arthritis

1.3 Market by Application

1.3.1 Global Pet Arthritis Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Dogs

1.3.3 Cats

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pet Arthritis Market Perspective (2018-2029)

2.2 Pet Arthritis Growth Trends by Region

2.2.1 Global Pet Arthritis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pet Arthritis Historic Market Size by Region (2018-2023)

2.2.3 Pet Arthritis Forecasted Market Size by Region (2024-2029)

2.3 Pet Arthritis Market Dynamics

2.3.1 Pet Arthritis Industry Trends

2.3.2 Pet Arthritis Market Drivers

2.3.3 Pet Arthritis Market Challenges

2.3.4 Pet Arthritis Market Restraints

3.1 Global Top Pet Arthritis Players by Revenue

3.1.1 Global Top Pet Arthritis Players by Revenue (2018-2023)

3.1.2 Global Pet Arthritis Revenue Market Share by Players (2018-2023)

3.2 Global Pet Arthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pet Arthritis Revenue

3.4 Global Pet Arthritis Market Concentration Ratio

3.4.1 Global Pet Arthritis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Arthritis Revenue in 2022

3.5 Pet Arthritis Key Players Head office and Area Served

3.6 Key Players Pet Arthritis Product Solution and Service

3.7 Date of Enter into Pet Arthritis Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pet Arthritis Historic Market Size by Type (2018-2023)

4.2 Global Pet Arthritis Forecasted Market Size by Type (2024-2029)

5.1 Global Pet Arthritis Historic Market Size by Application (2018-2023)

5.2 Global Pet Arthritis Forecasted Market Size by Application (2024-2029)

6.1 North America Pet Arthritis Market Size (2018-2029)

6.2 North America Pet Arthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pet Arthritis Market Size by Country (2018-2023)

6.4 North America Pet Arthritis Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pet Arthritis Market Size (2018-2029)

7.2 Europe Pet Arthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pet Arthritis Market Size by Country (2018-2023)

7.4 Europe Pet Arthritis Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pet Arthritis Market Size (2018-2029)

8.2 Asia-Pacific Pet Arthritis Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pet Arthritis Market Size by Region (2018-2023)

8.4 Asia-Pacific Pet Arthritis Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pet Arthritis Market Size (2018-2029)

9.2 Latin America Pet Arthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pet Arthritis Market Size by Country (2018-2023)

9.4 Latin America Pet Arthritis Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pet Arthritis Market Size (2018-2029)

10.2 Middle East & Africa Pet Arthritis Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pet Arthritis Market Size by Country (2018-2023)

10.4 Middle East & Africa Pet Arthritis Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Zoetis

11.1.1 Zoetis Company Detail

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Pet Arthritis Introduction

11.1.4 Zoetis Revenue in Pet Arthritis Business (2018-2023)

11.1.5 Zoetis Recent Development

11.2 Virbac

11.2.1 Virbac Company Detail

11.2.2 Virbac Business Overview

11.2.3 Virbac Pet Arthritis Introduction

11.2.4 Virbac Revenue in Pet Arthritis Business (2018-2023)

11.2.5 Virbac Recent Development

11.3 Elanco

11.3.1 Elanco Company Detail

11.3.2 Elanco Business Overview

11.3.3 Elanco Pet Arthritis Introduction

11.3.4 Elanco Revenue in Pet Arthritis Business (2018-2023)

11.3.5 Elanco Recent Development

11.4 Boehringer Ingelheim International GmbH

11.4.1 Boehringer Ingelheim International GmbH Company Detail

11.4.2 Boehringer Ingelheim International GmbH Business Overview

11.4.3 Boehringer Ingelheim International GmbH Pet Arthritis Introduction

11.4.4 Boehringer Ingelheim International GmbH Revenue in Pet Arthritis Business (2018-2023)

11.4.5 Boehringer Ingelheim International GmbH Recent Development

11.5 Ceva

11.5.1 Ceva Company Detail

11.5.2 Ceva Business Overview

11.5.3 Ceva Pet Arthritis Introduction

11.5.4 Ceva Revenue in Pet Arthritis Business (2018-2023)

11.5.5 Ceva Recent Development

11.6 Dechra Pharmaceuticals PLC.

11.6.1 Dechra Pharmaceuticals PLC. Company Detail

11.6.2 Dechra Pharmaceuticals PLC. Business Overview

11.6.3 Dechra Pharmaceuticals PLC. Pet Arthritis Introduction

11.6.4 Dechra Pharmaceuticals PLC. Revenue in Pet Arthritis Business (2018-2023)

11.6.5 Dechra Pharmaceuticals PLC. Recent Development

11.7 Vetoquinol

11.7.1 Vetoquinol Company Detail

11.7.2 Vetoquinol Business Overview

11.7.3 Vetoquinol Pet Arthritis Introduction

11.7.4 Vetoquinol Revenue in Pet Arthritis Business (2018-2023)

11.7.5 Vetoquinol Recent Development

11.8 NexGen Pharmaceuticals

11.8.1 NexGen Pharmaceuticals Company Detail

11.8.2 NexGen Pharmaceuticals Business Overview

11.8.3 NexGen Pharmaceuticals Pet Arthritis Introduction

11.8.4 NexGen Pharmaceuticals Revenue in Pet Arthritis Business (2018-2023)

11.8.5 NexGen Pharmaceuticals Recent Development

11.9 Norbrook

11.9.1 Norbrook Company Detail

11.9.2 Norbrook Business Overview

11.9.3 Norbrook Pet Arthritis Introduction

11.9.4 Norbrook Revenue in Pet Arthritis Business (2018-2023)

11.9.5 Norbrook Recent Development

11.10 Eltech K-Laser s.r.l.

11.10.1 Eltech K-Laser s.r.l. Company Detail

11.10.2 Eltech K-Laser s.r.l. Business Overview

11.10.3 Eltech K-Laser s.r.l. Pet Arthritis Introduction

11.10.4 Eltech K-Laser s.r.l. Revenue in Pet Arthritis Business (2018-2023)

11.10.5 Eltech K-Laser s.r.l. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pet Arthritis Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Osteoarthritis

    Table 3. Key Players of Other Arthritis

    Table 4. Global Pet Arthritis Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Pet Arthritis Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Pet Arthritis Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Pet Arthritis Market Share by Region (2018-2023)

    Table 8. Global Pet Arthritis Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Pet Arthritis Market Share by Region (2024-2029)

    Table 10. Pet Arthritis Market Trends

    Table 11. Pet Arthritis Market Drivers

    Table 12. Pet Arthritis Market Challenges

    Table 13. Pet Arthritis Market Restraints

    Table 14. Global Pet Arthritis Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Pet Arthritis Market Share by Players (2018-2023)

    Table 16. Global Top Pet Arthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Arthritis as of 2022)

    Table 17. Ranking of Global Top Pet Arthritis Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Pet Arthritis Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Pet Arthritis Product Solution and Service

    Table 21. Date of Enter into Pet Arthritis Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Pet Arthritis Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Pet Arthritis Revenue Market Share by Type (2018-2023)

    Table 25. Global Pet Arthritis Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Pet Arthritis Revenue Market Share by Type (2024-2029)

    Table 27. Global Pet Arthritis Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Pet Arthritis Revenue Market Share by Application (2018-2023)

    Table 29. Global Pet Arthritis Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Pet Arthritis Revenue Market Share by Application (2024-2029)

    Table 31. North America Pet Arthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Pet Arthritis Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Pet Arthritis Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Pet Arthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Pet Arthritis Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Pet Arthritis Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Pet Arthritis Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Pet Arthritis Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Pet Arthritis Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Pet Arthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Pet Arthritis Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Pet Arthritis Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Pet Arthritis Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Pet Arthritis Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Pet Arthritis Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Zoetis Company Detail

    Table 47. Zoetis Business Overview

    Table 48. Zoetis Pet Arthritis Product

    Table 49. Zoetis Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 50. Zoetis Recent Development

    Table 51. Virbac Company Detail

    Table 52. Virbac Business Overview

    Table 53. Virbac Pet Arthritis Product

    Table 54. Virbac Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 55. Virbac Recent Development

    Table 56. Elanco Company Detail

    Table 57. Elanco Business Overview

    Table 58. Elanco Pet Arthritis Product

    Table 59. Elanco Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 60. Elanco Recent Development

    Table 61. Boehringer Ingelheim International GmbH Company Detail

    Table 62. Boehringer Ingelheim International GmbH Business Overview

    Table 63. Boehringer Ingelheim International GmbH Pet Arthritis Product

    Table 64. Boehringer Ingelheim International GmbH Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 65. Boehringer Ingelheim International GmbH Recent Development

    Table 66. Ceva Company Detail

    Table 67. Ceva Business Overview

    Table 68. Ceva Pet Arthritis Product

    Table 69. Ceva Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 70. Ceva Recent Development

    Table 71. Dechra Pharmaceuticals PLC. Company Detail

    Table 72. Dechra Pharmaceuticals PLC. Business Overview

    Table 73. Dechra Pharmaceuticals PLC. Pet Arthritis Product

    Table 74. Dechra Pharmaceuticals PLC. Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 75. Dechra Pharmaceuticals PLC. Recent Development

    Table 76. Vetoquinol Company Detail

    Table 77. Vetoquinol Business Overview

    Table 78. Vetoquinol Pet Arthritis Product

    Table 79. Vetoquinol Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 80. Vetoquinol Recent Development

    Table 81. NexGen Pharmaceuticals Company Detail

    Table 82. NexGen Pharmaceuticals Business Overview

    Table 83. NexGen Pharmaceuticals Pet Arthritis Product

    Table 84. NexGen Pharmaceuticals Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 85. NexGen Pharmaceuticals Recent Development

    Table 86. Norbrook Company Detail

    Table 87. Norbrook Business Overview

    Table 88. Norbrook Pet Arthritis Product

    Table 89. Norbrook Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 90. Norbrook Recent Development

    Table 91. Eltech K-Laser s.r.l. Company Detail

    Table 92. Eltech K-Laser s.r.l. Business Overview

    Table 93. Eltech K-Laser s.r.l. Pet Arthritis Product

    Table 94. Eltech K-Laser s.r.l. Revenue in Pet Arthritis Business (2018-2023) & (US$ Million)

    Table 95. Eltech K-Laser s.r.l. Recent Development

    Table 96. Research Programs/Design for This Report

    Table 97. Key Data Information from Secondary Sources

    Table 98. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pet Arthritis Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pet Arthritis Market Share by Type: 2022 VS 2029

    Figure 3. Osteoarthritis Features

    Figure 4. Other Arthritis Features

    Figure 5. Global Pet Arthritis Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Pet Arthritis Market Share by Application: 2022 VS 2029

    Figure 7. Dogs Case Studies

    Figure 8. Cats Case Studies

    Figure 9. Others Case Studies

    Figure 10. Pet Arthritis Report Years Considered

    Figure 11. Global Pet Arthritis Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Pet Arthritis Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Pet Arthritis Market Share by Region: 2022 VS 2029

    Figure 14. Global Pet Arthritis Market Share by Players in 2022

    Figure 15. Global Top Pet Arthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Arthritis as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Pet Arthritis Revenue in 2022

    Figure 17. North America Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Pet Arthritis Market Share by Country (2018-2029)

    Figure 19. United States Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Pet Arthritis Market Share by Country (2018-2029)

    Figure 23. Germany Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Pet Arthritis Market Share by Region (2018-2029)

    Figure 31. China Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Pet Arthritis Market Share by Country (2018-2029)

    Figure 39. Mexico Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Pet Arthritis Market Share by Country (2018-2029)

    Figure 43. Turkey Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Pet Arthritis Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Zoetis Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 46. Virbac Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 47. Elanco Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 48. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 49. Ceva Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 50. Dechra Pharmaceuticals PLC. Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 51. Vetoquinol Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 52. NexGen Pharmaceuticals Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 53. Norbrook Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 54. Eltech K-Laser s.r.l. Revenue Growth Rate in Pet Arthritis Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed